Now Hiring: Pharmacist Researcher for the 2018 Access to Medicine Index
Monday, 13 March 2017
Access to Medicine Foundation
The Access to Medicine Foundation is strengthening the research teams involved in various project, and seeking a pharmacist researcher. The Foundation evaluated the pharmaceutical and vaccine companies on their policies and practices for improving access to medicine. The Foundation’s mission is to stimulate and guide pharmaceutical companies to do more to reach people living in low and middle income countries.
The Access to Medicine Foundation began with a single idea: how can we encourage the pharmaceutical industry to do more to help the global poor access the medicine they need? Its main tool is the Access to Medicine Index, which ranks the world’s largest pharmaceutical companies according to their efforts to improve access to medicine. The Foundation also publishes stand-alone studies about the pharmaceutical industry, a new Access to Vaccines Index, and an Antimicrobial Resistance Benchmark, It identifies best practices, highlights where progress is being made, and uncovers where critical action is still required. With these tools and outreach work, the Foundation provides both an incentive and a guide for pharmaceutical companies to do more to improve access to medicine. Each new product brings new opportunities to stimulate change and advance global debate on access to medicine. The Access to Medicine Foundation is an independent, international, not-for-profit organisation.
We are looking for one pharmacist researcher to join a support team for several projects in the Access to Medicine Foundation activities.
Main responsibilities will include:
- Contributing specific analyses needed to develop the methodology for any Indexes, Benchmark or thematic study, such as the evaluation of product portfolios
- Evaluation of company performance in access to medicines though data collection (from companies and independently)
- Identifying, analysing and presenting trends in access to medicine in relevant publications,
- Collaborating efficiently with other staff members, including those in charge of management, communications, or any Index/benchmark team, including those coordinating the operations of the Foundation and engagement with companies, taking on additional tasks as required,
- As required, presenting results in publications, conferences and meetings.
The Researcher will report to the Director of Research.
- An excellent analytical thinker, able to present accurate and up to date information
- A team player, willing to go the extra mile
- Have a good eye for detail
- Able to manage own time to achieve multiple projects and deadlines and identify risks and opportunities
- Able to deliver high quality, accurate and on-time analyses and insights
- Available to start as soon as possible in early 2017
- With a valid work permit to work in the Netherlands, EU applicants welcome.
- A relevant medical or pharmacist degree, recent graduates welcome.
- Experience with pharmaceutical products, including registration files and data mining for product characteristics and indications
- At least 1 year experience in analytical research in life science and health related fields
- At least 1 year experience working with large data sets and managing research projects
- Excellent command of English, both spoken and written (academic and media styles)
- Excellent skills in Microsoft Office, with solid experience in Microsoft Excel
- Having published on health-related topics in top-level academic journals and/or media a plus
- Experience in at least one of the following areas a plus: pharmaceutical pricing, pharmacoeconomics, (bio)pharmaceutical product development, regulation and market access, and/or intellectual property
- Skilled in both quantitative and qualitative analyses
- Experience working with or in the pharmaceutical industry (especially in the context of low and middle income countries) a plus
- Experience with SPSS or STATA a plus
- Fluency in the Dutch language a plus
Interested candidates should send a CV, two references and two writing samples to Mireille Deen, email@example.com.
Applications will be reviewed on a rolling basis, and interviews will take place in March-April 2017.
About the Access to Medicine Index
The Access to Medicine Index analyses 20 of the world’s largest research-based pharmaceutical companies with products for high-burden diseases in low- and middle-income countries. The Index ranks these companies according to their efforts to improve access to medicine in seven areas of corporate behaviour, including pricing, patents, ethical behaviour and donations. It covers 107 low- and middle-income countries and 50 high-burden diseases, and examines eight types of products, from medicines to vaccines to diagnostics. The Index identifies best practices, highlights where progress is being made, and uncovers where critical action is still required. In this way, the Index provides both an incentive and a guide for pharmaceutical companies to do more to improve access to medicine. It is published every two years by the Access to Medicine Foundation, an independent non-profit organisation.
About the Access to Medicine Foundation
The Access to Medicine Foundation is an independent, non-profit organisation based in the Netherlands. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in improving access to medicine. The Foundation is funded by the Bill & Melinda Gates Foundation, the Dutch Ministry of Foreign Affairs and the UK Department for International Development. For ten years, the Foundation has been building consensus on the role for the pharmaceutical industry in improving access to medicine and vaccines. It published its first benchmark of industry activity in this area in 2008, in the first Access to Medicine Index. The fifth Access to Medicine Index was published in November 2016. In 2017, the Foundation will publish the first Access to Vaccines Index, funded by the Dutch National Postcode Lottery, and the first Antimicrobial Benchmark, funded by the UK and Dutch governments.